Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)-Reference-Cited by-同舟云学术

Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)

Published:2020-05 Issue:5 Volume:75 Page:359-367
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Dixon Dave L.,Van Tassell Benjamin W.,Vecchié Alessandra,Bonaventura Aldo,Talasaz Azita H.,Kakavand Hessam,DʼAscenzo Fabrizio,Perciaccante Antonio,Castagno Davide,Ammirati Enrico,Biondi-Zoccai Giuseppe,Stevens Michael P.,Abbate Antonio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference43 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

3. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?

4. COVID-19 and the cardiovascular system

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting adoption of COVID-19 prevention measures among community members: A Case study of Entebbe Municipal council in Uganda;2024-05-06

2. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease;Natural Products and Bioprospecting;2024-01-29

3. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1;European Journal of Clinical Investigation;2023-10-14

4. Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19;BMC Geriatrics;2023-08-07

5. Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode;Internal Medicine;2023-08-01